130 related articles for article (PubMed ID: 35258389)
1. Effects of Subcutaneous Repository Corticotropin Gel Injection on Regulatory T Cell Population in Noninfectious Retinal Vasculitis.
Anesi SD; Chang PY; Maleki A; Manhapra A; Look-Why S; Asgari S; Walsh M; Drenen K; Foster CS
Ocul Immunol Inflamm; 2023 Apr; 31(3):556-565. PubMed ID: 35258389
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Noninfectious Retinal Vasculitis Using Subcutaneous Repository Corticotropin Injection.
Anesi SD; Chang PY; Maleki A; Stephenson A; Montieth A; Filipowicz A; Syeda S; Asgari S; Walsh M; Metzinger JL; Foster CS
J Ophthalmic Vis Res; 2021; 16(2):219-233. PubMed ID: 34055260
[TBL] [Abstract][Full Text] [Related]
3. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
[TBL] [Abstract][Full Text] [Related]
4. Repository Corticotropin Injection (Acthar
Wirta D; McLaurin E; Ousler G; Liu J; Kacmaz RO; Grieco J
Ophthalmol Ther; 2021 Dec; 10(4):1077-1092. PubMed ID: 34669183
[TBL] [Abstract][Full Text] [Related]
5. Management of repository corticotropin injection therapy for non-infectious uveitis: a Delphi study.
Nguyen QD; Anesi SD; Chexal S; Chu DS; Dayani PN; Leng T; Meleth AD; Sallam AA; Sheppard JD; Silverstein SM; Toyos M; Wang RC; Foster CS
Acta Ophthalmol; 2021 Sep; 99(6):669-678. PubMed ID: 33751822
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Repository Corticotropin Gel for Ocular Sarcoidosis.
Oh DJ; Singh A; Kanu LN; Lobo-Chan AM; MacIntosh PW; Bhat P
Ocul Immunol Inflamm; 2022 Aug; 30(6):1420-1424. PubMed ID: 33826473
[TBL] [Abstract][Full Text] [Related]
7. The Detection of Occult Retinal Vasculitis on Fluorescein Angiography in Pediatric Uveitis.
Abraham A; Saboo US; Ducca BL; Lawand AT; Ronconi C; Cao JH
Ophthalmol Retina; 2020 Feb; 4(2):198-203. PubMed ID: 31708487
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Characteristics of Noninfectious Occlusive Retinal Vasculitis.
Huvard MJ; Pecen PE; Palestine AG
Ophthalmol Retina; 2022 Jan; 6(1):43-48. PubMed ID: 33901715
[TBL] [Abstract][Full Text] [Related]
9. Cooperation with rheumatologists on intensive systemic treatment for psoriatic arthritis-related panuveitis with retinal vasculitis: a case report.
Wu PY; Kao CC; Sheu SJ
BMC Ophthalmol; 2022 Feb; 22(1):90. PubMed ID: 35197003
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States.
Nelson WW; Lima AF; Kranyak J; Opong-Owusu B; Ciepielewska G; Gallagher JR; Heap K; Carroll S
J Ocul Pharmacol Ther; 2019 Apr; 35(3):182-188. PubMed ID: 30676837
[TBL] [Abstract][Full Text] [Related]
11. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
Gilbert RM; Zhang X; Sampson RD; Ehrenstein MR; Nguyen DX; Chaudhry M; Mein C; Mahmud N; Galatowicz G; Tomkins-Netzer O; Calder VL; Lightman S
Front Immunol; 2018; 9():907. PubMed ID: 29774027
[TBL] [Abstract][Full Text] [Related]
12. Retinal vasculitis: A framework and proposal for a classification system.
Datoo O'Keefe GA; Rao N
Surv Ophthalmol; 2021; 66(1):54-67. PubMed ID: 32450158
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Epidemiological Profiles of Retinal Vasculitis in Northern Taiwan.
Wang LU; Chen FT; Chen YJ; Wang JK; Chang SW; Hsu YR
Ocul Immunol Inflamm; 2022 Feb; 30(2):310-317. PubMed ID: 32940544
[TBL] [Abstract][Full Text] [Related]
14. Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis.
Wu B; Deshpande G; Gu T; Popelar B; Philbin M; Wan GJ
J Med Econ; 2017 Nov; 20(11):1170-1177. PubMed ID: 28760047
[TBL] [Abstract][Full Text] [Related]
15. Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.
Mirsaeidi M; Baughman RP; Sahoo D; Tarau E
Pulm Ther; 2023 Jun; 9(2):237-253. PubMed ID: 37072607
[TBL] [Abstract][Full Text] [Related]
16. RETINAL VASCULITIS, A COMMON MANIFESTATION OF IDIOPATHIC PEDIATRIC UVEITIS?
Yang P; Zhong Z; Su G; Ye X; Tan S; Li F; Du L; Zhou C; Cao Q; Wang Y; Kijlstra A
Retina; 2021 Mar; 41(3):610-619. PubMed ID: 32658162
[TBL] [Abstract][Full Text] [Related]
17. Ocular signs predictive of tubercular uveitis.
Gupta A; Bansal R; Gupta V; Sharma A; Bambery P
Am J Ophthalmol; 2010 Apr; 149(4):562-70. PubMed ID: 20149341
[TBL] [Abstract][Full Text] [Related]
18. Tuberculous uveitis in China.
Mao Y; Peng XY; You QS; Wang H; Zhao M; Jonas JB
Acta Ophthalmol; 2014 Aug; 92(5):e393-7. PubMed ID: 24479692
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells and IL-17A levels in noninfectious uveitis.
Guedes MCE; Arroz MJ; Martins C; Angelo-Dias M; Proença RD; Borrego LM
Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1269-1278. PubMed ID: 32200408
[TBL] [Abstract][Full Text] [Related]
20. Change in visual acuity and retinal structures following Repository Corticotropin Injection (RCI) therapy in patients with acute demyelinating optic neuritis: Improvement in low contrast visual acuity in both affected and contralateral eyes in a single-armed open-label study.
Scannell Bryan M; Sergott RC
J Neurol Sci; 2019 Dec; 407():116505. PubMed ID: 31706456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
